相似文献
1
The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver.
Diabetol Metab Syndr. 2010 Mar 17;2:15. doi: 10.1186/1758-5996-2-15.
2
Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
Metabolism. 1999 Mar;48(3):330-7. doi: 10.1016/s0026-0495(99)90081-1.
3
Pathophysiology of Diabetic Dyslipidemia.
J Atheroscler Thromb. 2018 Sep 1;25(9):771-782. doi: 10.5551/jat.RV17023. Epub 2018 Jul 12.
4
Yam Gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK/ACC/CPT-1 pathway.
Lipids Health Dis. 2024 Jan 25;23(1):28. doi: 10.1186/s12944-024-02014-2.
5
Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
Clin Pharmacol Ther. 2003 Sep;74(3):236-44. doi: 10.1016/S0009-9236(03)00170-X.
6
VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
Diabetes. 1996 Jun;45(6):806-11. doi: 10.2337/diab.45.6.806.
7
Circulating lipoproteins and hepatic sterol metabolism in Psammomys obesus prone to obesity, hyperglycemia and hyperinsulinemia.
Atherosclerosis. 2001 Jul;157(1):85-96. doi: 10.1016/s0021-9150(00)00711-5.
8
Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
Ann Nutr Metab. 2010;56(3):198-206. doi: 10.1159/000276596. Epub 2010 Mar 4.
9
Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
Diabetes Care. 1994 Jan;17(1):6-12. doi: 10.2337/diacare.17.1.6.
10
Early lipid alterations in spontaneously diabetic rats.
Acta Physiol Pharmacol Ther Latinoam. 1998;48(4):228-34.
引用本文的文献
1
Diabetic encephalopathy: beneficial effects of supplementation with fatty acids ω3 and nordihydroguaiaretic acid in a spontaneous diabetes rat model.
Lipids Health Dis. 2019 Feb 8;18(1):43. doi: 10.1186/s12944-018-0938-7.
2
Long chain polyunsaturated fatty acids (LCPUFAs) and nordihydroguaiaretic acid (NDGA) modulate metabolic and inflammatory markers in a spontaneous type 2 diabetes mellitus model (Stillman Salgado rats).
Lipids Health Dis. 2016 Nov 25;15(1):205. doi: 10.1186/s12944-016-0363-8.
3
Comparative study on the effects of type 1 and type 2 diabetes on structural changes and hormonal output of the adrenal cortex in male Wistar rats.
J Diabetes Metab Disord. 2013 Jan 28;12(1):9. doi: 10.1186/2251-6581-12-9.
本文引用的文献
1
The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13).
PLoS One. 2009 Dec 24;4(12):e8464. doi: 10.1371/journal.pone.0008464.
2
Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
Clin Liver Dis. 2009 Nov;13(4):545-63. doi: 10.1016/j.cld.2009.07.009.
3
Liver fat and lipid oxidation in humans.
Liver Int. 2009 Oct;29(9):1439-46. doi: 10.1111/j.1478-3231.2009.02076.x. Epub 2009 Jul 7.
4
Saturated and unsaturated (including arachidonic acid) non-esterified fatty acid modulation of insulin secretion from pancreatic beta-cells.
Biochem Soc Trans. 2008 Oct;36(Pt 5):955-8. doi: 10.1042/BST0360955.
5
When HDL gets fat..
Circ Res. 2008 Jul 18;103(2):131-2. doi: 10.1161/CIRCRESAHA.108.180638.
6
Fatty liver, insulin resistance, and dyslipidemia.
Curr Diab Rep. 2008 Feb;8(1):60-4. doi: 10.1007/s11892-008-0011-4.
7
Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men.
Diabetologia. 2008 Jan;51(1):139-46. doi: 10.1007/s00125-007-0859-x. Epub 2007 Nov 17.
8
[Dynamic modifications in islets of Langerhans in two lines of spontaneously diabetic rats].
Medicina (B Aires). 2007;67(4):331-40.
9
Serum lipoprotein lipase mass: clinical significance of its measurement.
Clin Chim Acta. 2007 Mar;378(1-2):7-12. doi: 10.1016/j.cca.2006.12.003. Epub 2006 Dec 13.
Zotero 插件